Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2006
08/30/2006CN1826333A Diamine derivatives
08/30/2006CN1826321A Quinolone derivative or its salt
08/30/2006CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
08/30/2006CN1826116A Piperidine derivatives as melanocortin-4 receptor agonists
08/30/2006CN1826114A Enema agent
08/30/2006CN1824662A Substituted pyridine herbicides
08/30/2006CN1272329C Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents
08/30/2006CN1272326C Phenylpyridazine derivatives and drugs containing the same
08/30/2006CN1272324C Novel herbicides
08/30/2006CN1272316C Benzamides and related inhibitors of factor Xa
08/29/2006USRE39251 E.g., 7,11-Di(hydroxy)-8,8,10,12,16-pentamethyl-3-(1-methyl-2-(methylthiazol-4-yl)ethenyl)-4-aza-17-oxabicyclo(14.1.0)heptadecane-5,9-dione, preferably Form A; anticarcinogenic, -proliferative, -diabetic, -inflammatory agents; viricides; autoimmune diseases; psoriasis; agents; cardiovascular disorders
08/29/2006US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor
08/29/2006US7098340 Quinoline/chromene derivatives as androgen antagonist
08/29/2006US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
08/29/2006US7098325 For solid phase synthesis of phosphorothioate-containing antisense oligonucleotides; gene expression inhibition
08/29/2006US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes
08/29/2006US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
08/29/2006US7098234 Indole derivatives, process for preparation of the same and use thereof
08/29/2006US7098228 Indolyl derivatives
08/29/2006US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
08/29/2006US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
08/29/2006US7098215 Nitrogenous compounds and antiviral drugs containing the same
08/29/2006US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy
08/29/2006US7098212 Piperazine derivatives
08/29/2006CA2396738C Thiazole derivatives as active superoxide radical inhibitors
08/29/2006CA2201785C New carboxylic acid derivatives, their preparation and their use
08/24/2006WO2006089311A1 Vanilloid receptor ligands and their use in treatments
08/24/2006WO2006089060A1 Fungicidal pyrazine derivatives
08/24/2006WO2006088921A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006WO2006088919A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006WO2006088840A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
08/24/2006WO2006088837A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity
08/24/2006WO2006088129A1 Salt of proline derivative, solvate thereof, and production method thereof
08/24/2006WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
08/24/2006WO2006087897A1 Benzoisothiazole derivative and agent for controlling agricultural/horticultural plant disease
08/24/2006WO2006087543A1 Antibacterial piperidine derivatives
08/24/2006WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators
08/24/2006WO2006087309A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
08/24/2006WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors
08/24/2006WO2006035067A3 Hiv inhibiting 5-heterocyclyl pyrimidines
08/24/2006WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/24/2006WO2005097114A3 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
08/24/2006WO2005090333A8 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
08/24/2006WO2005070042A8 Novel chemical compounds
08/24/2006US20060189810 Novel sulfonamide inhibitors of aspartyl protease
08/24/2006US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
08/24/2006US20060189674 Deacetylase inhibitors
08/24/2006US20060189667 PPAR-activating compound and pharmaceutical composition comprising the compound
08/24/2006US20060189666 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide
08/24/2006US20060189660 5-(4-(2-N-methyl-N-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same
08/24/2006US20060189659 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione maleic acid salt
08/24/2006US20060189645 Novel 6-phenylphenantridines
08/24/2006US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors
08/24/2006US20060189630 Mitotic kinesin inhibitors
08/24/2006US20060189629 N-(2-morpholin-4-ylethyl)-1-(4-{[4-(trifluoromethoxy)benzyl]oxy}phenyl)-1H -benzimidazole-5-carboxamide; c-Kit proto-oncogene (stem cell factor receptor) anhibitor; tyrosine kinase inhibitor; antiproliferative, anticarcinogenic agent;
08/24/2006US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
08/24/2006US20060189603 such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions
08/24/2006US20060189594 Procedure for preparing a pharmaceutically active compound
08/24/2006US20060189593 Aryl spirohydantoin cgrp receptor antagonists
08/24/2006US20060189577 Tyrosine kinase inhibitors
08/24/2006CA2598897A1 Fungicidal pyrazine derivatives
08/24/2006CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598459A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
08/24/2006CA2598458A1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598457A1 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598456A1 Heterocyclic substituted piperazines with cxcr3 antagonist activity
08/24/2006CA2598423A1 Antibacterial piperidine derivatives
08/24/2006CA2598301A1 Salt of proline derivative, solvate thereof, and production method thereof
08/24/2006CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators
08/24/2006CA2596522A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
08/23/2006EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP1692117A1 Oxazole derivatives of tetracyclines
08/23/2006EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
08/23/2006EP1692111A2 Quinolines useful in treating cardiovascular disease
08/23/2006EP1692108A1 Novel herbicides
08/23/2006EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
08/23/2006EP1349855B1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt
08/23/2006EP1337529B1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
08/23/2006CN1823063A Quinoline derivatives as phosphodiesterase inhibitors
08/23/2006CN1823062A Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands
08/23/2006CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto
08/23/2006CN1823046A Phenyl quinolines and their use as estrogenic agents
08/23/2006CN1823043A Hydroxypyridine cgrp receptor antagonists
08/23/2006CN1823040A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
08/23/2006CN1821243A Substituted pyridine M receptor excitomotor, its preparing process and its use
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1821236A Therapeutic heterocyclic compounds
08/23/2006CN1271054C Urea compounds having muscarinic receptor antagonist activity
08/23/2006CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
08/22/2006US7094896 Diaminothiazoles having antiproliferative activity
08/22/2006US7094807 Viricides; hepatitis virus
08/22/2006US7094794 used for lowering the blood glucose and for the prevention and treatment of diabetes
08/22/2006US7094792 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/22/2006US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
08/22/2006US7094781 Sulfamides and their use as endothelin receptor antagonists